{
    "code": 0,
    "data": [
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Standalone and Consolidated Financial Results for the Third Quarter and Nine Months ended on December 31 2025.",
            "news_id": "52cff468-9657-4c89-bd8e-e85c982b8b52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6975260d-17bd-413a-a9cc-0f04f2b97a69.pdf",
            "news_date": "2026-02-11 23:04:28",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Third Quarter And Nine Months Ended On December On 31 2025",
            "news_body": "On review and recommendation of Audit Committee of the Company the Board approved Unaudited Standalone and Consolidated Financial Results for the Third Quarter and Nine months ended on December 31 2025",
            "news_id": "cd29ccd5-448e-49ab-986d-633782224a70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06532114-ee0d-4f9b-9ef1-e9a39ec3c4ff.pdf",
            "news_date": "2026-02-11 20:34:33",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2FY26 earning call held on November 14 2025",
            "news_id": "f2fedc7b-e0b4-44d5-8e09-9394a07e9e47",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2e1d840-994f-4249-8e2a-2721ae943b2c.pdf",
            "news_date": "2025-11-19 10:19:39",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Second quarter and half year ended 30th Septembre2025",
            "news_id": "5d46ed5c-1c0a-4b2d-9069-6d44c526e987",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f934c394-3b55-470f-b81b-acb031601389.pdf",
            "news_date": "2025-11-13 22:33:39",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Period Ended 30 September 2025",
            "news_body": "Approved Unaudited standalone and Consolidated financial results for the second quarter and half year ended \r\nSeptember 30 2025.",
            "news_id": "bd4aa607-de7a-40e5-968c-07e3b3276124",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae698aba-dfb5-445e-a99f-f63c2f3bc44a.pdf",
            "news_date": "2025-11-13 18:30:55",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY26 Earning call held on August 11 2025",
            "news_id": "9383fb95-312c-402e-b7bc-e3def6a669d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=addbb564-28e8-4082-9a21-e5db2523d4b7.pdf",
            "news_date": "2025-08-18 18:14:34",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results for the Q1 FY25-26",
            "news_id": "7f93b636-2672-4d89-9775-9a9b112fa5a2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f54b2085-70a6-491f-b5ce-a4d920857a6d.pdf",
            "news_date": "2025-08-10 12:44:35",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results Q1 FY 2025-2026",
            "news_body": "Financial Results Q1 FY 2025-2026",
            "news_id": "5573aa2e-e0ba-47cf-970b-c297a02eccfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53671625-8568-438f-a27c-13cdc3698d15.pdf",
            "news_date": "2025-08-08 17:16:13",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Pursuant to regulation 30 of SEBI(LODR)2015 on financial results for the quarter and year ended on 31st March 2025",
            "news_id": "c8d15b9c-cd15-4a21-8f4a-5ca29925d00c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f294d177-d40e-4b02-b999-cdaa5e026110.pdf",
            "news_date": "2025-05-30 11:19:47",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result",
            "news_body": "Financial result for Q4 and year ended on 31st March 2025",
            "news_id": "9ab6026e-4191-4e6f-b4d5-e2ff912c20ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52c992cc-a815-4891-b57c-61d4e1d61d67.pdf",
            "news_date": "2025-05-29 19:28:15",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed herewith the transcripts of Q3/9M-FY25 Earning Call held on the 14th February 2025",
            "news_id": "c486c8a5-4def-4cef-b096-1235aaf9a398",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2331ef6f-b29f-45a9-8504-a240ea1b4f36.pdf",
            "news_date": "2025-02-21 10:18:09",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on Financial results for the Third Quarter and nine months ended on 31st December2024 is enclosed herewith for record.",
            "news_id": "21eb7b1e-eede-4f86-8393-8e517c904b26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a663e669-b4cc-4831-bc9a-6beb45d3745c.pdf",
            "news_date": "2025-02-14 10:51:57",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": " Financial Results For The Period Ended 31 December 2024",
            "news_body": "Pursuant to  Regulation 30 and 33 of SEBI (LODR) regulations 2015 as amended from time to time. We enclosed herewith Unaudited Standalone and Consolidated Financial results of the company for the Third quarter and nine months ended on December 31 2024 along with the limited review reports with Unmodified Opinion Issued by M/s. BSR & Co. LLP The statutory Auditor.",
            "news_id": "3e25e778-14c9-4b1c-bd1b-4ebff40f3956",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8999cf0-e721-457c-be27-ee1974558c1c.pdf",
            "news_date": "2025-02-13 19:37:44",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcripts of the earning calls for the second quarter ended 30 September 2024 is enclosed herewith. Kindly take the same into your records.",
            "news_id": "f5d2b5d8-c21d-4003-8ad9-ab76d6513f3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b067a150-a0a4-454a-9225-2566e17b404a.pdf",
            "news_date": "2024-11-19 11:20:48",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI(LODR)Regulations, 2015 Investor Presentation on financial results for the second quarter and half year ended 30th September,2024 is enclosed. Kindly take note the records",
            "news_id": "d34ccc7f-668c-45ec-b03f-40c2f30098e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7e8f418-0766-43ce-a12b-d396a218b37a.pdf",
            "news_date": "2024-11-11 18:23:00",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Second Quarter And Half Year Ended September 30, 2024",
            "news_body": "Pursuant to Regulation 30 and 33 of the SEBI(LODR) regulations, 2015, as amended from time to time, we enclosed herewith the unaudited standalone and consolidated financial statement for the second quarter and half year ended September 2024, along with the limited review report with unmodified opinion issued by M/s. BSR & co. LLP, the statutory auditors.",
            "news_id": "2968dece-cd3a-4dc0-ae8a-17a6b8172ffd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca5c37c2-6f71-43c9-a9e4-3d7bb83d9f55.pdf",
            "news_date": "2024-11-11 13:08:07",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcripts of the earning calls for the first quarter ended June 30, 2024 is enclosed herewith.kindly take the same into your records.",
            "news_id": "616d84eb-e50f-4b67-8578-8090796e38b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd223f7b-18e4-401e-bbad-966b3a7d7533.pdf",
            "news_date": "2024-08-20 16:10:29",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, Investor Presentation on financial results for the first quarter ended June 30, 2024, is enclosedKindly take the above on records",
            "news_id": "45c2a93e-8f30-4358-8bd9-3f8120a660b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7020862e-ef39-4ed5-8d4a-3d94d5e1c5e0.pdf",
            "news_date": "2024-08-10 17:49:49",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For 30/06/2024",
            "news_body": "Unaudited Standalone and Consolidated Financial Statement for the first quarter ended june 30, 2024",
            "news_id": "ebce67a7-6a7b-4091-a803-f8df153f6546",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=def49d36-65f3-45b4-b277-fb476fecf70c.pdf",
            "news_date": "2024-08-09 13:41:19",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcripts of Q4 & FY24 Earning call Held on May 28, 2024",
            "news_id": "8698138b-9104-4762-8d93-f16fa1c5acaa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc48dcb9-a037-4f5b-a7cc-0fcf19011fb2.pdf",
            "news_date": "2024-06-04 11:12:07",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated May 21, 2024 to the Stock exchanges regarding Earning call in respect of the audited (Standalone and Consolidated) Financial Results of the company for the fourth Quarter and year ended March 31, 2024, we wish to inform that the said Earning Call was held today at 04:00 PM (IST).The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q4FY24-earning-call-audio.mp3 Kindly take the above on records.",
            "news_id": "12386946-2186-4ec9-89a1-cae549db89b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=414bb397-9c21-4af6-8d1d-b8d6c22f4b85.pdf",
            "news_date": "2024-05-28 18:52:51",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to regulation 30 of schedule III Part A (LODR) regulation 2015, Investor Presentation on financial results for the fourth quarter and year ended March 31, 2024 is enclosed. Kindly take the above on records.",
            "news_id": "5f50ad1e-4f2c-492a-9704-efa882da9e02",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d50132e-2d1e-4e4f-9cf6-2a7d3334fc5b.pdf",
            "news_date": "2024-05-27 18:21:08",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. Thursday, May 23, 2024- Audited Financial Results For The Quarter And Financial Year Ended On March 31, 2024",
            "news_body": "Outcome of Board meeting held today i.e thursday may 23,2024- Audited Financial Results for the quarter and financial year ended on March 31, 20241",
            "news_id": "63948fb3-e651-46d5-bc49-cfef6bb3f521",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e421ebd-5edf-4ba5-a85e-b84f5f0927c5.pdf",
            "news_date": "2024-05-23 15:36:46",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In Continuation of our letter dated February 09, 2024 regarding audio recording of the unaudited (Standalone and Consolidated) financial results of the company for the Third Quarter and Nine months ended December 31, 2023 , transcripts of the earnings call for the said period enclosed herewith and available on the website of the company at the following link after sending this letter to you,https://www.concordbiotech.com/investors",
            "news_id": "6f22e856-7f4d-4023-a669-07540fa93edb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc8098c1-b016-4bd2-b819-9ca4582d883f.pdf",
            "news_date": "2024-02-16 12:11:21",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated January 31, 2024 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Third Quarter and Nine Months ended December 31, 2023, we wish to inform that the said Earning Call was held today at 02:00 PM (IST).The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/q3fy24-earnings-audio-20240209175243.mp3 Kindly take the above on records.",
            "news_id": "55bba4fe-15ba-45f9-be56-8e53dd99d831",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0882b952-a87b-4455-bf61-eabfc9b639b8.pdf",
            "news_date": "2024-02-09 18:25:24",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Schedule III Part A of  SEBI (LODR) Regulations, 2015, investors presentation on the financial results for the Third Quarter and Nine months ended  December 31, 2023 is enclosed.",
            "news_id": "c3e25952-a6e4-486e-aae4-2277b5d7567b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5465ade3-836d-4325-aeec-0a78a0e382ea.pdf",
            "news_date": "2024-02-09 10:27:37",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Third Quarter And Nine Months Ended December 31, 2023",
            "news_body": "with reference to the intimation of Board meeting submitted on January 30, 2024, we would like inform you that the Board of Directors of the company , at its meeting held today i.e. Thursday, February 08, 2024, has inter-alia approved unaudited standalone and consolidated financial results for the third quarter and nine months ended on December 31, 2023.",
            "news_id": "97800eb4-e31a-42ea-921a-7a1864eade3e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1a456e7-9518-4655-b158-928a2ffab1eb.pdf",
            "news_date": "2024-02-08 18:15:57",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In Continuation of our letter dated November 09, 2023 regarding audio recording of the Unaudited (Standalone and consolidated) Financial results of the company for the quarter and half year ended September 30, 2023, Earnings call for investors and analysts and pursuant to regulation 30(6) of SEBI LODR, the transcripts of the earning call for the said period enclosed herewith.",
            "news_id": "ae981744-f28b-4d8e-ad91-e52c4b6caded",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acc254aa-b4db-4166-a5e5-90aac98859ff.pdf",
            "news_date": "2023-11-16 15:35:45",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated October 31, 2023 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Quarter and half year ended September 30, 2023, we wish to inform that the said Earning Call was held today at 03:00 PM (IST).The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q2FY24-Earnings-call-audio.mp3 Kindly take the above on records",
            "news_id": "57947ad9-42f5-4089-950a-2bf1288a8c51",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ad0039d-60f5-4e29-be78-d556a05301d4.pdf",
            "news_date": "2023-11-09 18:46:01",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to regulation 30 of Schedule III Part A of  SEBI (Listing Obligations and disclosure requirements) Regulations, 2015, investors presentation on financial results for the quarter and half year ended on September 30, 2023 is enclosed.",
            "news_id": "5abb6b32-c849-40f3-b2a5-e4247d0ef106",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ad51594-78eb-44e9-8596-1086644f93a5.pdf",
            "news_date": "2023-11-08 18:53:28",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E Wednesday, November 08, 2023- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "With reference to the intimation of Board meeting submitted on October 25, 2023, we would like to inform you that the Board of Directors of the Company, at its meeting held today i.e. Wednesday, November 08, 2023, has inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2023. The said results were also reviewed by the Audit Committee of the Company in its meeting held on November 08, 2023.<BR> <BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2023, along with the Limited Review Report of the Statutory auditors.<BR> <BR> The Board Meeting commenced at 11:00 AM and concluded at 03:00 P.M.<BR>",
            "news_id": "d47c5de7-dfab-4706-9b90-c8822c8da93c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d9a4f5e-3de5-44a6-85de-17e4d9cafa3f.pdf",
            "news_date": "2023-11-08 15:29:19",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E Wednesday, November 08, 2023- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "we would like to inform you that the Board of Directors of the company at its meeting held today i.e. Wednesday, 08th November, 2023 has inter-alia approved unaudited standalone and consolidated financial results for the quarter and half year ended september 30, 2023. the said results were also reviewed by the audit committee of the company in its meeting held on 08th November, 2023",
            "news_id": "78df3aba-67a4-4d64-8366-1e2992942911",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41aceab6-bfa6-48a8-bdce-7c7065676954.pdf",
            "news_date": "2023-11-08 15:19:03",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our letter dated September 07, 2023 regarding audio recording of Q1FY 24 earning call for investor and anaysts and pursuant to regulation 30(6) of SEBI LODR, Please find enclosed transcripts of  Q1 FY 24 earning call for the Quarter ended on June 30, 2023",
            "news_id": "59d357a7-c5f2-4f91-a1fd-addbb4b9456d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a010362-24c5-4b39-83f1-87b465d43b52.pdf",
            "news_date": "2023-09-13 16:17:01",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, and further to our intimation dated September 01, 2023 to the exchange regarding Earning call in respect of the Unaudited Financial Results of the company for the Quarter ended June 30, 2023, we wish to inform that the said Earning Call was held today at 4:00 PM (IST).The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :-  https://www.concordbiotech.com/public/assets/pdf/Q1FY24-Earnings-call.mpegKindly take the above on records.",
            "news_id": "dc1c65a3-ca32-46be-80d7-8e0910382e36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49086af9-f0c9-46ff-941f-0f8eb7061347.pdf",
            "news_date": "2023-09-07 18:22:25",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, a results presentation to analyst/investor for the period ended June 30,  2023 is enclosed.Kindly take the above on records.",
            "news_id": "fd3c2212-c7a0-4f07-b13c-acda73b7458b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e0f43a1-7f84-4f77-925f-6e1d719e109c.pdf",
            "news_date": "2023-09-06 20:25:02",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}